Insider Holders & Insider Ownership - Dyne Therapeutics Inc. (DYN)

List of insiders holdings for Dyne Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1Rhodes Jason P
Director
2025-01-29 16:15:050
9,130,465
9,130,465Form 4
2RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
2024-11-14 17:46:126,381,144
0
6,381,144Form 13G
3Forbion Capital Fund IV Cooperatief U.A.
10% Owner
2024-11-14 07:00:285,795,364
0
5,795,364Form 13G
4Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2024-11-14 16:32:405,714,057
0
5,714,057Form 13G
5Kersten Dirk
Director
2024-12-10 16:05:030
5,462,846
5,462,846Form 4
6MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
2024-02-12 16:06:323,451,303
0
3,451,303Form 13G
7Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2024-03-05 17:07:001,458,691
847,388
2,306,079Form 4
8VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner
2023-02-10 16:31:312,220,034
0
2,220,034Form 13D
9Logos Global Management LP
10% Owner
2023-02-14 15:53:472,150,000
0
2,150,000Form 13G
10Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
2020-09-23 18:56:451,608,785
0
1,608,785Form 4
11Brumm Joshua T
CEO & President
2024-03-12 21:56:20754,536
0
754,536Form 4
12Subramanian Romesh
Chief Scientific Officer
10% Owner
2020-09-18 17:12:38694,434
0
694,434Form 4
13CureDuchenne Ventures LLC
10% Owner
2020-09-23 19:05:52602,972
0
602,972Form 4
14Lucera Erick
Chief Financial Officer
2025-04-01 16:33:30280,600
0
280,600Form 4
15Beskrovnaya Oxana
Chief Scientific Officer
2025-03-13 16:08:14195,840
0
195,840Form 4
16Cox John
CEO & President
2025-03-07 16:07:03146,239
32,000
178,239Form 4
17Farwell Wildon
Chief Medical Officer
2024-08-20 16:27:16143,222
0
143,222Form 4
18McNeill Jonathan
Chief Business Officer
2024-08-20 16:27:39132,106
0
132,106Form 4
19HIGH SUSANNA GATTI
Chief Operating Officer
2024-09-19 16:52:28131,636
0
131,636Form 4
20Scalzo Richard William
SVP, Head of Finance & Admin.
2025-03-13 16:08:57122,330
0
122,330Form 4
21Friedl-Naderer Johanna
Chief Commercial Officer
2025-03-13 16:13:2696,057
0
96,057Form 4
22Kerr Douglas
Chief Medical Officer
2025-03-07 16:08:1494,157
0
94,157Form 4
23Stehman-Breen Catherine
Director
2024-05-24 17:10:2625,133
0
25,133Form 4
24HURWITZ EDWARD
Director
2024-05-24 17:10:1725,133
0
25,133Form 4
25Lubner David Charles
Director
2024-05-24 17:10:0925,133
0
25,133Form 4
26Incerti Carlo
Director
2024-11-18 19:42:0922,693
0
22,693Form 4
27Klein Lawrence Otto
Director
2022-07-06 18:20:167,222
0
7,222Form 4